Cat. #156518
Anti-Human cardiac troponin I (cTnI) scFv (4G5) [4G5scFv]
Cat. #: 156518
Unit size: 100 ug
Availability: 10-12 weeks
Target: Human cardiac troponin I
Class: Recombinant
Application: ELISA ; IP ; WB
Host: Chicken
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Paul Conroy ; Caroline Murphy
Institute: Dublin City University
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-Human cardiac troponin I (cTnI) scFv (4G5) [4G5scFv]
- Alternate name: cTnI
- Research fields: Tissue-specific biology
- Class: Recombinant
- Conjugation: Unconjugated
- Host: Chicken
- Application: ELISA ; IP ; WB
- Description: Cardiac Troponin I and T are proteins of the sarcomeric pool, widely recognised as the gold standard biomarkers for AMI diagnosis. The biomarkers also impact the patient prognosis, risk stratification and guide therapeutic intervention. The cardiac troponins (cTn) are markers of myocyte necrosis and take several hours to reach peak elevation after the onset of ischemia.
- Immunogen: TBC
- Immunogen uniprot id: TBC
Target Details
- Target: Human cardiac troponin I
- Target background: Cardiac Troponin I and T are proteins of the sarcomeric pool, widely recognised as the gold standard biomarkers for AMI diagnosis. The biomarkers also impact the patient prognosis, risk stratification and guide therapeutic intervention. The cardiac troponins (cTn) are markers of myocyte necrosis and take several hours to reach peak elevation after the onset of ischemia.
Applications
- Application: ELISA ; IP ; WB
Handling
- Format: Liquid
- Unit size: 100 ug
- Shipping conditions: Shipping at 4° C
References
- Conroy, P.J. (2011) Exploiting novel antibodies for the early detection of cardiac disease. PhD thesis, Dublin City University.
